• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.

作者信息

Bruns R F, Fergus J H, Coughenour L L, Courtland G G, Pugsley T A, Dodd J H, Tinney F J

机构信息

Department of Pharmacology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

出版信息

Mol Pharmacol. 1990 Dec;38(6):950-8.

PMID:2250667
Abstract

The structural requirements for stimulation of adenosine A1 agonist binding by 2-amino-3-benzoylthiophenes and related compounds were investigated. Slowing of the dissociation of [3H]N6cyclohexyladenosine binding was used as a specific measure of the allosteric effects of these compounds. The thiophene ring could be replaced with benzene but not with several nitrogen-containing heterocycles. The 2-amino group was required, and at least one hydrogen on the amino group appeared to be necessary for activity. The keto carbonyl was also essential. Alkyl substitution at the 4-position of the thiophene ring increased activity, whereas 5-position substitution appeared to have little effect. Activity was also increased by various substitutions on the phenyl ring, with 3-(trifluoromethyl) showing optimal activity. The phenyl ring could be replaced with cyclohexyl without major loss of activity. 1-Aminofluoren-9-one, a conformationally locked derivative, was active. Based in part in the latter observation, the active conformation is proposed to have an intramolecular hydrogen bond between the amino nitrogen and the carbonyl oxygen. Because the 2-amino-3-benzoylthiophenes showed competitive adenosine antagonism as well as allosteric enhancement, their affinities as competitive inhibitors of [3H]8-cyclopentyl-1,3-dipropylxanthine binding to A1 receptors were also assessed. Structure-activity relationships for competitive antagonism were distinct from those for allosteric enhancement, with ratios between the two activities varying by more than 1000-fold. Of the analogs tested, (2-amino-4,5-dimethyl-3-thienyl)-[3-(trifluoromethyl)phenyl]methanone (PD 81,723) had the most favorable ratio of enhancement to antagonism.

摘要

相似文献

1
Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
Mol Pharmacol. 1990 Dec;38(6):950-8.
2
Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptor.2-氨基-3-杂芳酰基噻吩的合成及其作为人A1受体潜在变构增强剂的活性评估。
Eur J Med Chem. 2004 Oct;39(10):855-65. doi: 10.1016/j.ejmech.2004.06.009.
3
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.新型2-氨基-3-萘甲酰基噻吩作为A1腺苷受体变构增强剂的合成及生物学效应
J Med Chem. 2003 Feb 27;46(5):794-809. doi: 10.1021/jm0210212.
4
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.2-氨基-3-苯甲酰基噻吩对腺苷A1受体结合及功能的变构增强作用
Mol Pharmacol. 1990 Dec;38(6):939-49.
5
Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.变构增强剂PD 81,723的腺苷A1受体依赖性和非依赖性作用
J Pharmacol Exp Ther. 1999 Feb;288(2):446-54.
6
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.用[3H]NECA标记的大鼠纹状体膜中A2腺苷受体的特性研究。
Mol Pharmacol. 1986 Apr;29(4):331-46.
7
Correlation between binding affinities for brain A1 and A2 receptors of adenosine agonists and antagonists and their effects on heart rate and coronary vascular tone.
J Pharmacol Exp Ther. 1988 Dec;247(3):882-8.
8
Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.对A1受体亚型具有选择性的强效腺苷受体拮抗剂。
Mol Pharmacol. 1987 Mar;31(3):247-52.
9
Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.苯乙基取代的嘧啶并[2,1-f]嘌呤二酮及相关化合物:作为腺苷A(1)和A(2A)受体配体的构效关系
Bioorg Med Chem. 2007 Nov 15;15(22):6956-74. doi: 10.1016/j.bmc.2007.07.051. Epub 2007 Aug 22.
10
Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.A1 腺苷受体的变构增强剂可增加受体与 G 蛋白的偶联,并抵消鸟嘌呤核苷酸对激动剂结合的影响。
Mol Pharmacol. 2003 Dec;64(6):1557-64. doi: 10.1124/mol.64.6.1557.

引用本文的文献

1
Structure-based discovery of positive allosteric modulators of the A adenosine receptor.基于结构的A1腺苷受体正变构调节剂的发现
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2421687122. doi: 10.1073/pnas.2421687122. Epub 2025 Jul 7.
2
The Brain-Heart Network of Syncope.晕厥的脑心网络
Int J Mol Sci. 2024 Jun 26;25(13):6959. doi: 10.3390/ijms25136959.
3
Small molecule allosteric modulation of the adenosine A receptor.小分子变构调节腺苷 A 受体。
Front Endocrinol (Lausanne). 2023 Jun 26;14:1184360. doi: 10.3389/fendo.2023.1184360. eCollection 2023.
4
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications.腺苷受体变构调节剂的最新进展及其治疗应用
Front Pharmacol. 2022 Oct 5;13:1030895. doi: 10.3389/fphar.2022.1030895. eCollection 2022.
5
Automated in vivo compound screening with zebrafish and the discovery and validation of PD 81,723 as a novel angiogenesis inhibitor.利用斑马鱼进行自动化体内化合物筛选,发现并验证 PD 81,723 是一种新型血管生成抑制剂。
Sci Rep. 2022 Aug 25;12(1):14537. doi: 10.1038/s41598-022-18230-8.
6
Retrospective ensemble docking of allosteric modulators in an adenosine G-protein-coupled receptor.回顾性集合对接法研究别构调节剂在腺苷 G 蛋白偶联受体中的作用。
Biochim Biophys Acta Gen Subj. 2020 Aug;1864(8):129615. doi: 10.1016/j.bbagen.2020.129615. Epub 2020 Apr 13.
7
Probe dependence of allosteric enhancers on the binding affinity of adenosine A -receptor agonists at rat and human A -receptors measured using NanoBRET.使用 NanoBRET 测量大鼠和人 A 受体上腺苷 A -受体激动剂的结合亲和力,研究变构增强剂对探针的依赖性。
Br J Pharmacol. 2019 Apr;176(7):864-878. doi: 10.1111/bph.14575. Epub 2019 Mar 6.
8
Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A Receptor.别构药物配体在腺苷 A 受体中结合的结构基础。
Sci Rep. 2018 Nov 15;8(1):16836. doi: 10.1038/s41598-018-35266-x.
9
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.变构调节 A 类 G 蛋白偶联受体:靶点、药物及新的概念。
J Med Chem. 2019 Jan 10;62(1):88-127. doi: 10.1021/acs.jmedchem.8b00875. Epub 2018 Aug 28.
10
Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors.预测相关化学系列的腺苷和毒蕈碱型乙酰胆碱受体的正变构调节剂的共识结合模式几何形状。
J Comput Chem. 2017 Jun 5;38(15):1209-1228. doi: 10.1002/jcc.24728. Epub 2017 Jan 28.